Abstract
A series of β-cyclodextrin/3-tigloyl-azdirachtol inclusion complexes were prepared from β-cyclodextrin, heptakis( 2,3,6-tri-O-methyl)-β-cyclodextrin, mono(6-ethylene-diamino-6-deoxy)-β-cyclodextrin and mono(6-diethylenetriamino- 6-deoxy)-β-cyclodextrin with 3-tigloyl-azdirachtol (azadirachtin B, AZ-B) in ca. 90%, and their inclusion complexation behaviors were investigated by means of UV/Vis, 1H NMR and 2D NMR spectroscopy. The results showed that the AZ-B could be efficiently encapsulated in the cyclodextrin cavity in aqueous solution to produce complexes that were more stabilized than free AZ-B. Furthermore, the water solubility of AZ-B was obviously increased to high levels up to 4-6.3 mg/ml (calculated as AZ-B) after inclusion complexation with cyclodextrins. This satisfactory water solubility and high stability of the cyclodextrin – AZ-B complexes will be potentially useful, for their application as biopesticide and herbal medicine or healthcare products. The enhanced binding ability of cyclodextrins toward AZ-B was discussed from the viewpoint of the size/shape – fit concept and multiple recognition mechanism between host and guest.
Keywords: 3-Tigloyl-azadirachtol, Azadirachtin B, %-Cyclodextrin, Inclusion complexation, Supra-molecular chemistry
Current Pharmaceutical Analysis
Title: Inclusion Complexation Behaviors of 3-Tigloyl-Azadirachtol with β-Cyclodextrin Derivatives
Volume: 4 Issue: 3
Author(s): Bo Yang, Yong Chen, Jun Lin and Yu Liu
Affiliation:
Keywords: 3-Tigloyl-azadirachtol, Azadirachtin B, %-Cyclodextrin, Inclusion complexation, Supra-molecular chemistry
Abstract: A series of β-cyclodextrin/3-tigloyl-azdirachtol inclusion complexes were prepared from β-cyclodextrin, heptakis( 2,3,6-tri-O-methyl)-β-cyclodextrin, mono(6-ethylene-diamino-6-deoxy)-β-cyclodextrin and mono(6-diethylenetriamino- 6-deoxy)-β-cyclodextrin with 3-tigloyl-azdirachtol (azadirachtin B, AZ-B) in ca. 90%, and their inclusion complexation behaviors were investigated by means of UV/Vis, 1H NMR and 2D NMR spectroscopy. The results showed that the AZ-B could be efficiently encapsulated in the cyclodextrin cavity in aqueous solution to produce complexes that were more stabilized than free AZ-B. Furthermore, the water solubility of AZ-B was obviously increased to high levels up to 4-6.3 mg/ml (calculated as AZ-B) after inclusion complexation with cyclodextrins. This satisfactory water solubility and high stability of the cyclodextrin – AZ-B complexes will be potentially useful, for their application as biopesticide and herbal medicine or healthcare products. The enhanced binding ability of cyclodextrins toward AZ-B was discussed from the viewpoint of the size/shape – fit concept and multiple recognition mechanism between host and guest.
Export Options
About this article
Cite this article as:
Yang Bo, Chen Yong, Lin Jun and Liu Yu, Inclusion Complexation Behaviors of 3-Tigloyl-Azadirachtol with β-Cyclodextrin Derivatives, Current Pharmaceutical Analysis 2008; 4 (3) . https://dx.doi.org/10.2174/157341208785161272
DOI https://dx.doi.org/10.2174/157341208785161272 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery The Hunt for New Tuberculosis Vaccines: Anti-TB Immunity and Rational Design of Vaccines
Current Pharmaceutical Design Hemoglobin Degrading Proteases of Plasmodium falciparum as Antimalarial Drug Targets
Current Drug Targets Fish and Apoptosis: Studies in Disease and Pharmaceutical Design
Current Pharmaceutical Design Immunological Mechanism and Clinical Application of PAMP Adjuvants
Recent Patents on Anti-Cancer Drug Discovery Reversal of Tumor Induced Dendritic Cell Paralysis: A Treatment Regimen Against Cancer
Current Immunology Reviews (Discontinued) New Trends in Development of Antimycobacterial Compounds
Infectious Disorders - Drug Targets A Role of the 9-Aminoacridines and their Conjugates in a Life Science
Current Protein & Peptide Science Interaction of Host Pattern Recognition Receptors (PRRs) with <i>Mycobacterium Tuberculosis</i> and Ayurvedic Management of Tuberculosis: A Systemic Approach
Infectious Disorders - Drug Targets Quinolinyl-Thienyl Chalcones as Monoamine Oxidase Inhibitors and their In Silico Modeling Studies
Medicinal Chemistry Drug Metabolizing Enzymes and Transporters mRNA in Peripheral Blood Mononuclear Cells of Healthy Subjects: Biological Variations and Importance of Preanalytical Steps
Current Drug Metabolism Chaperone-like Activity of alpha-Crystallin and Other Small Heat Shock Proteins
Current Protein & Peptide Science Optimal Antibiotic Therapy in the Management of the Lung of the Critically Ill
Current Respiratory Medicine Reviews Recent Patents Regarding Essential Oils and the Significance of their Constituents in Human Health and Treatment
Recent Patents on Anti-Infective Drug Discovery Synthesis and Pharmacological Activities of Oxadiazole and Pyrimidine Bearing Thiocoumarin Derivatives
Current Microwave Chemistry Recent Development and Application of Virtual Screening in Drug Discovery: An Overview
Current Pharmaceutical Design subject Index To Volume 3
Current Drug Targets The Diagnosis of Drug-Induced Liver Disease
Current Clinical Pharmacology Stereochemistry at the Forefront in the Design and Discovery of Novel Anti-tuberculosis Agents
Current Topics in Medicinal Chemistry Cytokines in Candidiasis and Aspergillosis
Current Pharmaceutical Biotechnology